Latest oppositions filed by Ipsen Pharma S.a.s.

This table presents recent patent oppositions filed by Ipsen Pharma S.a.s. against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3432916Stabilized Non-Protein Clostridial Toxin CompositionsALLERGAN, INC.May 12, 2020
EP3436054Stabilized Non-Protein Clostridial Toxin CompositionsALLERGAN, INC.May 12, 2020
EP2692350Lyophilized Preparation Of Botulinum ToxinMEDY-TOX INC.Feb 2, 2018

The following table provides an overview of the latest patents of Ipsen Pharma S.a.s. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2957278May 17, 2017A Stable Composition Comprising Pthrp And Uses Thereof2
EP2249847Apr 12, 2017Novel Method For Preparing Extracts Of Ginkgo Biloba1